SAGE - Sage Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 58.97B
Enterprise Value 37.05B
Trailing P/E N/A
Forward P/E 1-14.69
PEG Ratio (5 yr expected) 1-0.94
Price/Sales (ttm)98.86
Price/Book (mrq)6.78
Enterprise Value/Revenue 377.68
Enterprise Value/EBITDA 6-14.57

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-534.47%

Management Effectiveness

Return on Assets (ttm)-24.02%
Return on Equity (ttm)-38.82%

Income Statement

Revenue (ttm)90.74M
Revenue Per Share (ttm)1.92
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-191.83M
EBITDA -483.66M
Net Income Avi to Common (ttm)-461.69M
Diluted EPS (ttm)-9.79
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.35B
Total Cash Per Share (mrq)26.42
Total Debt (mrq)41.68M
Total Debt/Equity (mrq)3.16
Current Ratio (mrq)20.06
Book Value Per Share (mrq)25.86

Cash Flow Statement

Operating Cash Flow (ttm)-332.03M
Levered Free Cash Flow (ttm)-160.35M

Trading Information

Stock Price History

Beta (3Y Monthly) 3.20
52-Week Change 315.45%
S&P500 52-Week Change 34.92%
52 Week High 3178.16
52 Week Low 379.88
50-Day Moving Average 3168.17
200-Day Moving Average 3140.74

Share Statistics

Avg Vol (3 month) 3508.03k
Avg Vol (10 day) 3484.3k
Shares Outstanding 551.15M
Float 49.79M
% Held by Insiders 12.71%
% Held by Institutions 198.75%
Shares Short (Apr 30, 2019) 44.56M
Short Ratio (Apr 30, 2019) 49.2
Short % of Float (Apr 30, 2019) 413.00%
Short % of Shares Outstanding (Apr 30, 2019) 48.92%
Shares Short (prior month Mar 29, 2019) 44.51M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A